Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prostatic hypertrophy treatment claims for saw palmetto draw FDA "courtesy" letters.

This article was originally published in The Tan Sheet

Executive Summary

BPH TREATMENT CLAIMS DRAW FDA "COURTESY" LETTERS for structure/function claims that suggest the dietary supplements are "intended to treat, mitigate, or pre-vent a disease, namely benign prostatic hypertrophy," FDA says. One letter was sent to Celestial Seasonings, which had notified the agency in January it was using the structure/function claims "Helps maintain healthy, comfortable urinary flow and frequency" and "Natural support for men over age 40" for its Celestial Seasonings Saw Palmetto Standardized Herbal Extract. The firm has not decided whether it will change the claims.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088446

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel